---
title: "Allakos (ALLK.US) — 公司概况"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ALLK.US/overview.md"
symbol: "ALLK.US"
name: "Allakos"
parent: "https://longbridge.com/zh-CN/quote/ALLK.US.md"
datetime: "2026-04-05T08:09:21.185Z"
locales:
  - [en](https://longbridge.com/en/quote/ALLK.US/overview.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ALLK.US/overview.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ALLK.US/overview.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/ALLK.US/overview.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ALLK.US/overview.md)


# Allakos (ALLK.US) — 公司概况

## 基本信息

| 项目 | 详情 |
|------|--------|
| 行业 | Biotechnology |
| 交易所 | US Market |

## 公司简介

Allakos Inc., a clinical stage biotechnology company, engages in the development of therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company was incorporated in 2012 and is headquartered in San Carlos, California.


---

> **免责声明: 本文仅供参考，不构成任何投资建议。**